These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 3954645)
1. Ocular toxicity of intravitreal vidarabine solubilized in dimethyl sulfoxide. Yoshizumi MO; Niizawa JM; Meyers-Elliott R Arch Ophthalmol; 1986 Mar; 104(3):426-30. PubMed ID: 3954645 [TBL] [Abstract][Full Text] [Related]
2. Ocular toxicity after intravitreal injection of terconazole. Schulman JA; Peyman GA; Dietlein J; Fiscella R; Colantino B Ann Ophthalmol; 1989 Sep; 21(9):345-7. PubMed ID: 2817662 [TBL] [Abstract][Full Text] [Related]
3. Toxicity of intravitreal antiviral drugs. Pulido JS; Palacio M; Peyman GA; Fiscella R; Greenberg D; Stelmack T Ophthalmic Surg; 1984 Aug; 15(8):666-9. PubMed ID: 6483372 [TBL] [Abstract][Full Text] [Related]
4. Ocular toxicity of experimental intravitreal itraconazole. Schulman JA; Peyman GA; Dietlein J; Fiscella R Int Ophthalmol; 1991 Jan; 15(1):21-4. PubMed ID: 1849126 [TBL] [Abstract][Full Text] [Related]
5. Experimental intravitreal ketoconazole in DMSO. Yoshizumi MO; Banihashemi AR Retina; 1988; 8(3):210-5. PubMed ID: 3266021 [TBL] [Abstract][Full Text] [Related]
6. Ara AMP- a highly soluble new antiviral drug. Pavan-Langston D; North RD; Geary PA Ann Ophthalmol; 1976 May; 8(5):571-9. PubMed ID: 937940 [TBL] [Abstract][Full Text] [Related]
7. Intraocular properties of an alkoxyalkyl derivative of cyclic 9-(S)-(3-hydroxyl-2-phosphonomehoxypropyl) adenine, an intravitreally injectable anti-HCMV drug in rabbit and guinea pig. Tammewar AM; Cheng L; Hostetler KY; Falkenstein I; Beadle JR; Barron EC; Kozak I; Freeman WR J Ocul Pharmacol Ther; 2007 Oct; 23(5):433-44. PubMed ID: 17900229 [TBL] [Abstract][Full Text] [Related]
9. Toxicity of intravitreal oxiconazole. Schulman JA; Peyman GA; Dietlein J; Fiscella R Int Ophthalmol; 1989 May; 13(3):201-3. PubMed ID: 2793313 [TBL] [Abstract][Full Text] [Related]
10. Intravitreal toxicology and duration of efficacy of a novel antiviral lipid prodrug of ganciclovir in liposome formulation. Cheng L; Hostetler KY; Chaidhawangul S; Gardner MF; Beadle JR; Keefe KS; Bergeron-Lynn G; Severson GM; Soules KA; Mueller AJ; Freeman WR Invest Ophthalmol Vis Sci; 2000 May; 41(6):1523-32. PubMed ID: 10798672 [TBL] [Abstract][Full Text] [Related]
11. Ocular and systemic toxicity of intravitreal topotecan in rabbits for potential treatment of retinoblastoma. Buitrago E; Del Sole MJ; Torbidoni A; Fandino A; Asprea M; Croxatto JO; Chantada GL; Bramuglia GF; Schaiquevich P Exp Eye Res; 2013 Mar; 108():103-9. PubMed ID: 23333535 [TBL] [Abstract][Full Text] [Related]
12. Ocular and systemic antiviral activity of vidarabine. Pavan-Langston D; Hess F Compr Ther; 1977 Jul; 3(7):42-8. PubMed ID: 195767 [No Abstract] [Full Text] [Related]
13. Retinal toxicity of combination antiviral drugs in an animal model. Small GH; Peyman GA; Srinivasan A; Smith RT; Fiscella R Can J Ophthalmol; 1987 Oct; 22(6):300-3. PubMed ID: 3123041 [TBL] [Abstract][Full Text] [Related]
14. [Arabinosyladenine in ophthalmology (author's transl)]. Colin J J Fr Ophtalmol; 1981; 4(6-7):525-30. PubMed ID: 7028853 [TBL] [Abstract][Full Text] [Related]
15. Toxicity of intravitreal injection of fluconazole in the rabbit. Schulman JA; Peyman G; Fiscella R; Small G; Coats M; Wajszczuk CP; Steahly L Can J Ophthalmol; 1987 Oct; 22(6):304-6. PubMed ID: 2827871 [TBL] [Abstract][Full Text] [Related]
16. Comparative efficacy of 5-methoxymethyl-2'-deoxyuridine, 9 beta-D-arabinofuranosyladenine and 5-iodo-2'-deoxyuridine in the treatment of experimental herpes simplex keratitis. Meldrum JB; Gupta VS; Babiuk LA Chemotherapy; 1980; 26(1):54-63. PubMed ID: 7353440 [TBL] [Abstract][Full Text] [Related]
17. Intraocular penetration of the soluble antiviral, Ara AMP. Pavan-Langston D; North RD; Geary PA; Kinkel A Arch Ophthalmol; 1976 Sep; 94(9):1585-8. PubMed ID: 962668 [TBL] [Abstract][Full Text] [Related]
18. Ac2IDU, BVDU, and thymine arabinoside therapy in experimental herpes keratitis. Hettinger ME; Pavan-Langston D; Park NH; Albert DM; De Clercq E; Lin TS Arch Ophthalmol; 1981 Sep; 99(9):1618-21. PubMed ID: 7283815 [TBL] [Abstract][Full Text] [Related]
19. Current trends in therapy of ocular herpes simplex: experimental and clinical studies. Pavan-Langston D Adv Ophthalmol; 1979; 38():82-8. PubMed ID: 93409 [No Abstract] [Full Text] [Related]
20. Effect of iontophoretic and topical application of antiviral agents in treatment of experimental HSV-1 keratitis in rabbits. Kwon BS; Gangarosa LP; Park NH; Hull DS; Fineberg E; Wiggins C; Hill JM Invest Ophthalmol Vis Sci; 1979 Sep; 18(9):984-8. PubMed ID: 90030 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]